This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
An experimental COPD drug from Sanofi and Regeneron showed mixed results in a pa...
The combined impacts of an immigration crackdown and slashing Medicaid budgets c...
Medicare wants a tech upgrade to address difficulties patients face in accessing...
Little noticed, the ACA reforms in the tax bill could lower enrollment about as ...
The U.S. solicitor general agreed with the appeals court on three provisions of ...
The White House will fix errors in a much-anticipated federal government report ...
On this week's podcast, STAT's Helen Branswell talks about BARDA cancelling its ...
In this edition of STAT's Health Tech newsletter: New health care marketplace wi...
This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about ...
HHS has notified Moderna that it is canceling a nearly $600 million contract for...
And more biotech updates brought to you by The Readout.
In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna con...
A startup seeking to replace animal testing with a sophisticated high-tech platf...
Instead of approving Stealth BioTherapeutics' drug for Barth syndrome, the FDA w...
“We are squandering trillions of dollars, often to the detriment of our patients...
Radiologists interpret more than 40 million mammograms in the United States ever...
You can’t fact-check fear, and other lessons from successful campaigns against a...
HHS has notified Moderna that it is canceling a nearly $600 million contract for...
General Medicine, launched by three former Amazon employees has a business model...
The recent dismissal of 13 FDA review staff eliminated precisely the kind of gov...
RFK Jr.'s unilateral decision to revise Covid booster guidance represents a bull...
Amid a measles outbreak that's the nation's largest in more than two decades, Te...
And more can't-miss biotech news brought to you by The Readout.